Delivery Order SPE2DB22D2214-SPE2DB26FS2LY
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,840.88 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injections, with a completion date of September 30, 2025. This firm fixed-price delivery order, issued as a non-competitive award, represents a single pharmaceutical procurement under AmerisourceBergen's broader supply relationship with DLA. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,344.53 for Mounjaro 7.5 mg/0.5 mL pen injections on October 21, 2025, with an ultimate completion date of October 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designations and will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a single transaction under AmerisourceBergen's larger pharmaceutical supply vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $3,326.28 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 ml pen injections. This non-set-aside, competitively awarded contract was issued on September 9, 2025, with an ultimate completion date of September 10, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The firm fixed price delivery order represents a routine pharmaceutical procurement for military...
- The Defense Logistics Agency awarded a delivery order valued at $2,448.81 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 ml pen injections. This competitive, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of September 10, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $4,647.49 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 ml pen injections. This competitively awarded, firm fixed-price contract was executed on September 15, 2025, with an ultimate completion date of September 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under a larger contracting vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $1,454.04 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 mL pen injections. This competitively awarded, firm fixed-price delivery order was issued on August 7, 2025, with an ultimate completion date of August 8, 2025. The pharmaceutical supply will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a non-set-aside procurement, this award reflects open...
- The Defense Logistics Agency awarded a $5,441.80 delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Mounjaro 15 mg/0.5 ml pen injectors. The contract is a firm fixed-price delivery order with an ultimate completion date of September 23, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's capability to compete for...
- The Defense Logistics Agency awarded a $7,583.88 delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 ml pen injectors on April 24, 2025, with completion scheduled for April 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a small-value transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the company's facility in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,644.62 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors on July 25, 2025, with a completion date of July 28, 2025. This is a firm fixed-price, non-competitive delivery order with no set-aside designation, issued to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award represents a standard pharmaceutical procurement supporting the federal government's...
- The Defense Logistics Agency has awarded a delivery order valued at $2,448.81 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 ml pen injections in 0.5 ml units. This firm fixed-price delivery order, issued on August 4, 2025, with completion targeted for August 5, 2025, represents a small-value pharmaceutical procurement under DLA's medical supply chain operations. The award was made on a competitive basis with no set-aside designation, reflecting AmerisourceBergen's...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB26FS2LYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,546.13 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injections on October 22, 2025, with completion scheduled for October 23, 2025. This is a firm fixed-price delivery order with no set-aside designation, placing performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a single-line item transaction within AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. This delivery order is issued under AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications and medical supplies to military healthcare programs and other federal healthcare systems. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated consistent capability to meet federal procurement requirements through competitive contracting and maintains an extensive portfolio of medical product deliveries across multiple therapeutic domains, including specialty medications, vaccines, and medical devices supporting Defense Health Agency and other government healthcare customers worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 10/22/25 |